跳至主要内容
临床试验/NCT02009215
NCT02009215已完成4 期

'SCHOOL-BASED TREATMENT WITH ACT TO REDUCE TRANSMISSION' (START-IPT): Evaluation of the Community Impact of Intermittent Preventive Treatment for Malaria in Ugandan Children: a Cluster Randomised Trial

London School of Hygiene and Tropical Medicine1 个研究点 分布在 1 个国家目标入组 10,746 人开始时间: 2014年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
10,746
试验地点
1
主要终点
Parasite prevalence measured by microscopy in final community survey

研究概览

简要总结

We propose to evaluate the community-level impact of intermittent preventive treatment (IPT) for malaria in schoolchildren on clinical outcomes and malaria transmission, using a cluster-randomised design in Jinja, Uganda. Dihydroartemisinin-piperaquine (DP) will be administered to schoolchildren monthly for up to six rounds of treatment during one school year. Outcomes will be measured using surveys of communities, schoolchildren, and mosquito vectors. Our proposal also includes health service research to evaluate the potential feasibility of taking the programme to scale, which will guide future research and implementation of the intervention, and help shape policies in Uganda and elsewhere in Africa.

详细描述

Study objective: The primary objective of the study is to evaluate the impact of IPT for malaria in schoolchildren using monthly DP, as compared with the current standard of care (no IPT), on community-level indicators of malaria transmission. We will test the hypothesis that malaria transmission, as measured by the prevalence of asexual parasitaemia and the entomological inoculation rate (EIR), will be lower in communities surrounding the intervention schools, than those surrounding the control schools.

Study site: The study will be conducted in Jinja district, Uganda.

Clusters: A cluster will be defined as one primary day school plus the 100 closest households surrounding the school. The clusters will be defined prior to randomisation using digitally enumerated maps. We plan to include approximately 84 clusters in the study, with one school per cluster; half will be randomised to the IPT intervention, and half to control.

Randomisation: Randomisation will be conducted by the trial statistician, who is not directly involved in the field activities. Primary schools will be stratified by type of ownership (public vs private). Restricted randomisation will be employed to ensure balance on type of school and geographical location.

Study population: The intervention will be delivered to children attending participating primary schools that are randomised to the intervention group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
5 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Student enrolled in a participating intervention school.
  • Willingness of parent/guardian to provide written informed consent.
  • Provision of written assent by the student (aged 8 years or above).

排除标准

  • Age < 5 years
  • Known allergy or history of adverse reaction to DP
  • Menarche in female students
  • Weight < 11 kg
  • History of cardiac problems or fainting
  • Family history of long QT syndrome
  • Current use of medications known to prolong the QT interval
  • Not able to locate parent or guardian, after at least three attempts including parent/teacher association (PTA) meetings and home visits
  • Not able to locate the student at school, after at least three attempts

研究组 & 干预措施

Intermittent preventive treatment (IPT)

Experimental

Dihydroartemisinin-piperaquine (DP)

干预措施: Dihydroartemisinin-piperaquine (DP) (Drug)

结局指标

主要结局

Parasite prevalence measured by microscopy in final community survey

时间窗: Approximately 1-4 months after completion of the intervention

Proportion of thick blood smears that are positive for asexual parasites, as measured by microscopy.

次要结局

  • Parasite prevalence measured by microscopy in the final school survey(During the final 1 month of the intervention)
  • Entomologic inoculation rate (EIR) in the entomology survey(Over approximately 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Staedke

Principal Investigator

London School of Hygiene and Tropical Medicine

研究点 (1)

Loading locations...

相似试验

School-Based Treatment With ACT to Reduce... | 临床试验